These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 15765779)

  • 21. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
    Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
    Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis.
    Garcia-Chavez J; Majluf-Cruz A; Montiel-Cervantes L; Esparza MG; Vela-Ojeda J;
    Ann Hematol; 2007 Dec; 86(12):871-7. PubMed ID: 17874322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New treatment methods for autoimmune thrombocytopenia].
    Koene HR
    Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2609-14. PubMed ID: 18161261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging strategies to treat chronic immune thrombocytopenic purpura.
    Newland A
    Eur J Haematol Suppl; 2008 Feb; (69):27-33. PubMed ID: 18211570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune thrombocytopenia: no longer 'idiopathic'.
    McCrae K
    Cleve Clin J Med; 2011 Jun; 78(6):358-73. PubMed ID: 21632906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current therapies in primary immune thrombocytopenia.
    Pels SG
    Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of adult idiopathic thrombocytopenic purpura.
    Cines DB; McMillan R
    Annu Rev Med; 2005; 56():425-42. PubMed ID: 15660520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of a patient with chronic immune thrombocytopenic purpura with rituximab and monitoring by flow cytometric analysis.
    Thude H; Gruhn B; Werner U; Schorner U; Häfer R; Zintl F; Barz D
    Acta Haematol; 2004; 111(4):221-4. PubMed ID: 15153715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R; Pagano A; Stipa E; Amadori S
    Blood; 2001 Aug; 98(4):952-7. PubMed ID: 11493438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reassessment of treatment modalities for paediatric patients with chronic immune thrombocytopenia.
    Laws HJ; Janssen G; Borkhardt A
    Hamostaseologie; 2009 May; 29(2):171-6. PubMed ID: 19404521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab: an anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura.
    Aggarwal A; Catlett JP
    South Med J; 2002 Oct; 95(10):1209-12. PubMed ID: 12425512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and therapy of idiopathic thrombocytopenic purpura (ITP) in adults].
    Chrobák L
    Vnitr Lek; 2002 Aug; 48(8):773-80. PubMed ID: 12425210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of immune thrombocytopenia: a retrospective study of 40 patients].
    Audia S; Lakomy D; Guy J; Leguy-Seguin V; Berthier S; Aho S; Lorcerie B; Bonnotte B
    Rev Med Interne; 2010 May; 31(5):337-44. PubMed ID: 20409619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag.
    Chouhan JD; Herrington JD
    Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study.
    Godeau B; Porcher R; Fain O; Lefrère F; Fenaux P; Cheze S; Vekhoff A; Chauveheid MP; Stirnemann J; Galicier L; Bourgeois E; Haiat S; Varet B; Leporrier M; Papo T; Khellaf M; Michel M; Bierling P
    Blood; 2008 Aug; 112(4):999-1004. PubMed ID: 18463354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refractory idiopathic immune thrombocytopenic purpura in children: current and future treatment options.
    Imbach P
    Paediatr Drugs; 2003; 5(12):795-801. PubMed ID: 14658921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.